crown

Subscribe Now

FOLLOW US

Sign in

covaxin

PAGE 2

Covaxin production to be temporarily slowed down 'foreseeing decrease in demand'

Published on Apr 2, 2022 01:28 IST

Covaxin got the WHO's approval for emergency use last year. ((PIC FOR REPRESENTATION))

Received nod to hold Covaxin clinical trials in US: Bharat Biotech

On February 2 last year, Ocugen had also announced an exclusive licensing agreement with Bharat Biotech to obtain exclusive rights to develop, manufacture and commercialise Covaxin in the US. (HT File)

Updated on Feb 19, 2022 19:22 IST

US to evaluate Covaxin as vaccine candidate

Ocugen is developing Covaxin in partnership with Bharat Biotech in the US and Canada.

Published on Feb 19, 2022 16:34 IST

Covishield, Covaxin get conditional market nod

Gurugram: A health worker administers a dose of Covid-19 vaccine to a beneficiary, at a vaccination centre in Gurugram, Thursday, January 27, 2022. (PTI Photo)(PTI01_27_2022_000068A) (PTI)

Published on Jan 27, 2022 18:31 IST

Covaxin, Covishield to be available in hospitals, clinics; apex body gives nod

Covaxin, Covishield to be available in regular market, apex body gives nod

Updated on Jan 27, 2022 09:50 IST

Evening brief from HT: Akhilesh dismisses opinion polls on TV as ‘opium polls’

Samajwadi Party national president Akhilesh Yadav

Published on Jan 26, 2022 11:39 IST

Covaxin, Covishield to get cheaper after nod, jabs to be priced at ₹275

According to current rates, each dose of the Bharat Biotech-produced Covaxin is priced at <span class='webrupee'>₹</span>1,200, while Serum Institute’s Covishield costs <span class='webrupee'>₹</span>780 in private facilities. (Representational image)

Published on Jan 26, 2022 11:27 IST

Panel pitches full market nod for Covaxin, Covishield

A healthworker administers a dose of Covid-19 vaccine to a beneficiary at a vaccination centre, in Gurugram. (PTI photo)

Updated on Jan 20, 2022 24:38 IST

SEC recommends Covaxin, Covishield for full market authorisation: Report

A doctor being inoculated with a booster dose of Covid-19 vaccine, at Ganga Ram Hospital, in New Delhi. (Amal KS/HT Photo)

Updated on Jan 19, 2022 17:14 IST

Bharat Biotech again urges health staff to be ‘vigilant’ while jabbing teenagers

A medic administers Covid vaccine to a teen in Ludhiana at the civil surgeon’s office. The vaccination drive for this group began on January 3. (HT Photo)

Updated on Jan 18, 2022 15:09 IST

DCGI needs more safety data for Covaxin nod for under 12

A Municipal Corporation worker administers a dose of Covid-19 vaccine to a teenager, at a municipal school in Thane. (PTI)

Updated on Jan 17, 2022 23:15 IST

Govt seeks more data for full market clearance to Covishield, Covaxin

Patna: A health worker administers a COVID-19 vaccine dose to a teenanger, at SKM Hall in Patna, Friday, Jan. 14, 2022. (PTI Photo)(PTI01_14_2022_000164A) (PTI)

Updated on Jan 14, 2022 20:10 IST

Covaxin booster shot neutralises Omicron, says Bharat Biotech

A booster shot of Covaxin is administered six months after the last of two doses.

Published on Jan 12, 2022 13:40 IST

Holds promise: ICMR on trial results of third dose of Covaxin

Prime Minister Narendra Modi, in a televised address on December 25, 2021, announced precaution doses for healthcare and frontline workers from January 10 and Covid-19 jabs for the teenagers aged 15-18 years.

Updated on Jan 9, 2022 17:20 IST

Trials show Covaxin safe for booster dose, says Bharat Biotech

Reactogenicity after vaccine and placebo was minimal and comparable, and no serious adverse events were reported, the company said referring to the trial results.

Updated on Jan 8, 2022 16:14 IST

Only Covaxin to be administered to 15-18 age group, cautions Bharat Biotech

Bharat Biotech's Covaxin vaccine is the only vaccine with emergency use listing for the 15-18 age group, the health ministry said last week.

Published on Jan 7, 2022 22:36 IST

No painkiller recommended for children vaccinated with Covaxin: Bharat Biotech

India opened up vaccination with Covaxin for children aged 15-18 after the company received approval from the Drug Controller General of India (DCGI).

Published on Jan 5, 2022 13:15 IST

Same vaccine to be administered as ‘precaution’ 3rd dose: Centre

A Covaxin vial is seen during a vaccination drive against the Covid-19 coronavirus during a vaccination drive for youths in the 15-18 age group, at a school in Kolkata on January 4, 2022. (Photo by DIBYANGSHU SARKAR / AFP)

Published on Jan 5, 2022 11:07 IST

Covid-19: Vaccination of children aged between 15 and 18 begins today

Girls from 15 to 18 years of age register for Covid-19 vaccination on the Co-WIN platform in Tiruchirappalli on Saturday.

Published on Jan 3, 2022 24:35 IST

Covaxin safe, immunogenic in 2-18 age group: Bharat Biotech

Bharat Biotech on Thursday said that its vaccine was found to be ‘safe, well-tolerated, and immunogenic’ in phase 2/3 clinical trials on children in the 2-18 years age group.

Updated on Dec 30, 2021 23:20 IST

Vaccination for 15-18 years: Only Covaxin likely to be administered

Covaxin has got the nod from the DCGI for emergency use on children on December 25.

Published on Dec 26, 2021 17:31 IST

DCGI approves Covaxin for emergency use in age group between 12 and 18 years

The Drugs Controller General of India (DCGI) on Saturday granted approval for restricted use in emergency situation to Bharat Biotech’s Covaxin in the paediatric age group between 12 and 18 years. (HT PHOTO.)

Updated on Dec 25, 2021 19:42 IST

Opened vials of Covaxin can be stored for up to 28 days: Bharat Biotech

Bharat Biotech said the multidose vial policy would save money for procurement agencies by reducing cold chain logistics.

Published on Dec 20, 2021 15:14 IST

Additional information sought: MoS health informs Parliament on Covaxin for kids

Bharat Biotech's Covaxin received the emergency use listing (EUL) from the World Health Organisation (WHO) on November 3.

Updated on Nov 30, 2021 16:42 IST

Canada to allow travellers vaccinated with Covaxin from today

Apart from Bharat Biotech, Canada has also approved China's Sinopharm and Sinovac vaccines against Covid-19.

Published on Nov 30, 2021 01:03 IST

‘An evidence of effectiveness’: Bharat Biotech on real-world study of Covaxin

Image used only for representative purpose (PTI)

Published on Nov 25, 2021 03:56 IST

Third dose of vaccine not needed in India yet: AIIMS chief on booster shots

Dr Randeep Guleria, Director of the All India Institute of Medical Sciences (AIIMS).

Updated on Nov 24, 2021 12:25 IST

Covaxin 50% effective against Delta variant: Real-world study

Covaxin in clinical trials had an estimated efficacy of 65% when the more infectious Delta variant was taken into account. (Agencies)

Updated on Nov 25, 2021 24:45 IST

From November 30, Canada to allow entry to people vaccinated with Covaxin

Bharat Biotech Covaxin (File Photo)

Published on Nov 22, 2021 08:51 IST

UK rules recognising Covaxin for inbound travel come into effect from today

A healthcare worker fills a syringe with a dose of Covaxin at a municipal health centre in Kolkata.

Published on Nov 22, 2021 24:55 IST

1
2

Home / India News / Covaxin

© 2026 HindustanTimes